CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

Clinical Trial26 Sep 2019

JOURNAL:Circulation. Article Link

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial

S Windecker , RD Lopes, AUGUSTUS Investigators et al. Keywords: antithrombotic therapy; atrial fibrillation; ACS patients; safety and efficacy

FULL TEXT PDF